Up to 80% of these tests turn out to be normal, an increasing trend that has been observed over the last years. 4 Associated with this trend are increasing healthcare costs and exposure of the patient to radiation and/or contrast agents. 5 , 6 Simple, safe, and cost-efficient diagnostic pathways for patients with suspected functionally relevant CAD (fCAD) still remain an unmet clinical need.
← all excerpts
Combining anatomical and biochemical markers in the detection and risk stratification of coronary artery disease.
1
—
—